Amedisys (AMED) Tops Q4 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Amedisys (AMED) Could Help Transform Healthcare - Mizuho
March 10, 2016 7:39 AM ESTMizuho analyst, Sheryl Skolnick, thinks Amedisys Inc's (NASDAQ: AMED) turnaround continues to impress as it proceeds on multiple fronts, driving better than expected 4Q15 results, meaningful 2016 improvements and likely strong 2017 growth. Increasing transparency into the progress, costs, timing and returns to the turnaround strategies are making the Street increasingly confident and supported a strong move in the stock. The analyst thinks AMED is strongly positioned not only as a post-acute... More



